View of EVALUATING THE NEUROENDOCRINE AND METABOLIC IMPLICATIONS OF SERTRALINE THERAPY IN DIABETIC PATIENTS WITH SEVERE DEPRESSION

Return to Article Details EVALUATING THE NEUROENDOCRINE AND METABOLIC IMPLICATIONS OF SERTRALINE THERAPY IN DIABETIC PATIENTS WITH SEVERE DEPRESSION Download Download PDF